ATA129-EBV-302: Multi-center, Open Label, Phase 3 Study of Tablecleucel for Solid Organ Transplant Subjects with Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disease after Failure of Rituximab and Chemother

Project: Research project

Project Details

StatusActive
Effective start/end date5/14/198/31/50

Funding

  • Atara Biotherapeutics